ACLE (Average Cohort Life Expectancy) is the survivorship-weighted average of the life expectancies at birth of all cohorts alive at a given time . Proposed by Schoen and Canudas-Romo (2005), it answers the question "what is the average life expectancy of the people alive right now?" — a question answered by neither period life expectancy (LE) (a synthetic-cohort construct) nor cohort LE (only one birth cohort) nor the Cross-Sectional Average Length of Life (CAL) (which is sensitive to past mortality fluctuations). The weight given to age is the cohort's actual probability of surviving to that age, .
The denominator equals CAL(t) (the cross-sectional average length of life), so ACLE is also the expectation of cohort LEs under the CAL density .
Four-measure hierarchy under declining mortality:
Cohort LE > ACLE > Period LE > CAL
Under constant mortality all four are equal. ACLE is always intermediate between cohort and period LE, and above CAL under declining mortality. The ratio of ACLE to cohort LE is approximately in a Gompertz model with constant improvement rate and age-gradient .
ACLE vs. CAL — the tempo sensitivity problem: CAL was proposed by Bongaarts and Feeney (2002) as a tempo-robust alternative to period LE. Schoen and Canudas-Romo (2005) show this claim fails. In a pure-tempo scenario (timing shifts that leave all cohort LEs fixed), period LE and CAL each fluctuate by more than 2 years, while ACLE remains exactly flat (since it is determined solely by cohort LEs). CAL is sensitive to timing changes because it integrates past cohort survival probabilities, which encode the history of mortality at all ages — including past timing shifts.
CAL as a lagged average of period LEs: After a mortality level shift at , , where declines roughly exponentially. Even 20 years after the shift, 24% of the weight still attaches to the pre-shift level. CAL is thus history-sensitive in a way ACLE is not.
ACLE is insensitive to timing changes that don't affect cohort LE: This follows directly from the definition. ACLE depends only on the completed life expectancies of active cohorts, not on when within those cohorts deaths occur. If a timing shift compresses deaths into younger ages for a cohort (raising period LE) but does not change that cohort's completed LE, ACLE is unchanged.
Empirical relationship to period LE: Under Scenario A (constant future mortality), ACLE lies between period LE and cohort LE throughout the 1880–2000 histories of England/Wales, Norway, and Switzerland. Under Scenario B (continuing improvement at per year), ACLE exceeds period LE in recent decades — suggesting that published period life expectancies currently understate the average longevity of living cohorts.
ACLE decomposition: . The first term is the cohort-survivorship-weighted average of cohort LE improvements (the direct component); the second is a covariance between cohort LE levels and cohort growth rates. In all three countries, the direct term dominates; the covariance term is small and negative (~10% of the direct term), partially offsetting improvement.
Slope relationships: In continually declining mortality models, ACLE improvement rate ≈ arithmetic mean of cohort and period LE improvement rates. Cohort LE diverges from period LE and CAL over time; ACLE stays roughly parallel to both.
At time , the persons alive at age belong to the cohort born at . That cohort's completed life expectancy (from birth) is . The number of people of that cohort alive at time per unit birth is . ACLE sums the product over all ages and divides by the total population count — which equals CAL(t) under constant births. The result is the cohort-survivorship-weighted mean of all active cohorts' life expectancies.
Practical computation requires: